Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy - PubMed (original) (raw)
Review
doi: 10.1038/nrc1821.
Affiliations
- PMID: 16498445
- DOI: 10.1038/nrc1821
Review
Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Christopher M Overall et al. Nat Rev Cancer. 2006 Mar.
Abstract
The matrix metalloproteinases (MMPs) mediate homeostasis of the extracellular environment. They have multiple signalling activities that are commonly altered during tumorigenesis and that might serve as intervention points for anticancer drugs. However, there are many criteria to consider in validating MMPs as drug targets and for the development of MMP inhibitors. The inhibition of some MMPs could have pro-tumorigenic effects (making them anti-targets), counterbalancing the benefits of target inhibition. These effects might partially account for the failure of MMP inhibitors in clinical trials. What are the major challenges in MMP target validation and MMP-inhibitor-drug development?
Similar articles
- [Expression of matrix metalloproteinases in patients with malignant tumors].
Stanciūte D, Didziapetriene J, Kadziauskas J. Stanciūte D, et al. Medicina (Kaunas). 2004;40(12):1143-50. Medicina (Kaunas). 2004. PMID: 15630339 Review. Lithuanian. - Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Coussens LM, Fingleton B, Matrisian LM. Coussens LM, et al. Science. 2002 Mar 29;295(5564):2387-92. doi: 10.1126/science.1067100. Science. 2002. PMID: 11923519 Review. - Matrix metalloproteinases. Novel targets for directed cancer therapy.
Yu AE, Hewitt RE, Connor EW, Stetler-Stevenson WG. Yu AE, et al. Drugs Aging. 1997 Sep;11(3):229-44. doi: 10.2165/00002512-199711030-00006. Drugs Aging. 1997. PMID: 9303281 Review. - Matrix metalloproteinases and cancer - roles in threat and therapy.
Yadav L, Puri N, Rastogi V, Satpute P, Ahmad R, Kaur G. Yadav L, et al. Asian Pac J Cancer Prev. 2014;15(3):1085-91. doi: 10.7314/apjcp.2014.15.3.1085. Asian Pac J Cancer Prev. 2014. PMID: 24606423 Review. - Pigment epithelium-derived factor as a natural matrix metalloproteinase inhibitor: a comparison with classical matrix metalloproteinase inhibitors used for cancer treatment.
Alcantara MB, Dass CR. Alcantara MB, et al. J Pharm Pharmacol. 2014 Jul;66(7):895-902. doi: 10.1111/jphp.12218. Epub 2014 Feb 12. J Pharm Pharmacol. 2014. PMID: 24697787 Review.
Cited by
- BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis.
Wan Q, Dingerdissen H, Fan Y, Gulzar N, Pan Y, Wu TJ, Yan C, Zhang H, Mazumder R. Wan Q, et al. Database (Oxford). 2015 Mar 28;2015:bav019. doi: 10.1093/database/bav019. Print 2015. Database (Oxford). 2015. PMID: 25819073 Free PMC article. - Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.
Soleyman-Jahi S, Nedjat S, Abdirad A, Hoorshad N, Heidari R, Zendehdel K. Soleyman-Jahi S, et al. PLoS One. 2015 Apr 28;10(4):e0122316. doi: 10.1371/journal.pone.0122316. eCollection 2014. PLoS One. 2015. PMID: 25919283 Free PMC article. - Selection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1.
Lu G, Zheng M, Zhu Y, Sha M, Wu Y, Han X. Lu G, et al. Int J Biol Sci. 2012;8(5):650-62. doi: 10.7150/ijbs.3897. Epub 2012 May 5. Int J Biol Sci. 2012. PMID: 22606046 Free PMC article. - Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.
Bhowmick M, Stawikowska R, Tokmina-Roszyk D, Fields GB. Bhowmick M, et al. Chembiochem. 2015 May 4;16(7):1084-92. doi: 10.1002/cbic.201402716. Epub 2015 Mar 12. Chembiochem. 2015. PMID: 25766890 Free PMC article. - Optical imaging of tumor microenvironment.
Wu Y, Zhang W, Li J, Zhang Y. Wu Y, et al. Am J Nucl Med Mol Imaging. 2013;3(1):1-15. Epub 2013 Jan 5. Am J Nucl Med Mol Imaging. 2013. PMID: 23342297 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources